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Type II Secretion-Dependent Aminopeptidase LapA and
Acyltransferase PlaC Are Redundant for Nutrient Acquisition
during Legionella pneumophila Intracellular Infection of
Amoebas
Richard C. White,a Felizza F. Gunderson,a Jessica Y. Tyson,a Katherine H. Richardson,b Theo J. Portlock,b James A. Garnett,b
Nicholas P. Cianciottoa
aDepartment of Microbiology and Immunology, Northwestern University Medical School, Chicago, Illinois, USA
bDepartment of Chemistry and Biochemistry, Queen Mary University of London, London, United Kingdom
ABSTRACT Legionella pneumophila genes encoding LapA, LapB, and PlaC were identi-
fied as the most highly upregulated type II secretion (T2S) genes during infection of
Acanthamoeba castellanii, although these genes had been considered dispensable on
the basis of the behavior of mutants lacking either lapA and lapB or plaC. A plaC mutant
showed even higher levels of lapA and lapB transcripts, and a lapA lapB mutant showed
heightening of plaC mRNA levels, suggesting that the role of the LapA/B aminopepti-
dase is compensatory with respect to that of the PlaC acyltransferase. Hence, we made
double mutants and found that lapA plaC mutants have an ~50-fold defect during infec-
tion of A. castellanii. These data revealed, for the first time, the importance of LapA in
any sort of infection; thus, we purified LapA and defined its crystal structure, activation
by another T2S-dependent protease (ProA), and broad substrate specificity. When the
amoebal infection medium was supplemented with amino acids, the defect of the lapA
plaC mutant was reversed, implying that LapA generates amino acids for nutrition. Since
the LapA and PlaC data did not fully explain the role of T2S in infection, we identified,
via proteomic analysis, a novel secreted protein (NttD) that promotes infection of A. cas-
tellanii. A lapA plaC nttD mutant displayed an even greater (100-fold) defect, demonstrat-
ing that the LapA, PlaC, and NttD data explain, to a significant degree, the importance
of T2S. LapA-, PlaC-, and NttD-like proteins had distinct distribution patterns within and
outside the Legionella genus. LapA was notable for having as its closest homologue an
A. castellanii protein.
IMPORTANCE Transmission of L. pneumophila to humans is facilitated by its ability to
grow in Acanthamoeba species. We previously documented that type II secretion (T2S)
promotes L. pneumophila infection of A. castellanii. Utilizing transcriptional analysis
and proteomics, double and triple mutants, and crystal structures, we defined three
secreted substrates/effectors that largely clarify the role of T2S during infection of
A. castellanii. Particularly interesting are the unique functional overlap between an
acyltransferase (PlaC) and aminopeptidase (LapA), the broad substrate specificity and
eukaryotic-protein-like character of LapA, and the novelty of NttD. Linking LapA to
amino acid acquisition, we defined, for the first time, the importance of secreted
aminopeptidases in intracellular infection. Bioinformatic investigation, not previously
applied to T2S, revealed that effectors originate from diverse sources and distribute
within the Legionella genus in unique ways. The results of this study represent a ma-
jor advance in understanding Legionella ecology and pathogenesis, bacterial secre-
tion, and the evolution of intracellular parasitism.
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One of 62 species in Legionella (1), Legionella pneumophila is an inhabitant of watersystems and the main agent of Legionnaires’ disease, a pneumonia of increasing
prevalence (2, 3). Disease largely results from inhalation of contaminated droplets from
aerosolizing devices (4). In aquatic habitats, the Gram-negative bacterium L. pneumo-
phila flourishes as an intracellular parasite of amoebas, especially species of Acantham-
oeba, Vermamoeba, and Naegleria (5, 6). Within lungs, L. pneumophila grows in mac-
rophages, residing, as it does in amoebas, in a membrane-bound compartment, the
Legionella-containing vacuole (LCV) (7, 8). Critical to infection is a type IV secretion
system (T4SS), which translocates myriad effectors from the LCV into the host cyto-
plasm (9–11).
Type II secretion (T2S) is another major factor in L. pneumophila pathogenesis (12,
13). The T2S system (T2SS) promotes infection of the lungs, enhancing Legionella
growth in macrophages, dampening the host cytokine response, and releasing dam-
aging enzymes (14–16). While the T2SS does not impact entry into macrophages or
evasion of lysosomes, it does promote replication in the LCV at 4 to 12 h postentry (17).
T2S is also critical for L. pneumophila survival in water and for infection of Acantham-
oeba castellanii, Naegleria lovaniensis, and Vermamoeba vermiformis (18–24). T2S also
potentiates L. pneumophila biofilm formation and sliding motility (25, 26). During T2S,
protein substrates first move across the inner membrane via the Sec or Tat pathway;
once in the periplasm, they are recognized by the T2SS apparatus, which uses a
pseudopilus to drive the proteins through an outer membrane channel (13, 27). On the
basis of proteomic and enzymatic analysis of supernatants, we discerned that L. pneu-
mophila T2S elaborates at least 27 proteins, including nearly 20 enzymes and novel
proteins of unknown activity (13, 28, 29). T2S-dependent proteins known to promote
infection of key amoebal hosts include the novel NttA protein, which facilitates
infection of A. castellanii; the novel NttC protein, which fosters infection of V. vermifor-
mis; and acyltransferase PlaC, metalloprotease ProA, and RNase SrnA, which enhance
infection of V. vermiformis and N. lovaniensis (23, 24, 30, 31). Overall, L. pneumophila T2S
is one of the best-characterized T2SSs, in terms of its output and functions (13). Yet
there are gaps in knowledge; e.g., the exoproteins thus far linked to infection do not
fully explain the impact of T2SS on L. pneumophila ecology. On the basis of a form of
transcriptional analysis and proteomics, we have now used genetic, biochemical,
bioinformatic, and structural biology methods to define a eukaryotic-protein-like ami-
nopeptidase and a novel secreted protein that provide unique insight into the evolu-
tion of T2S and parasitism.
RESULTS
Transcriptional analysis identified T2SS-dependent LapA, LapB, and PlaC as
hyperexpressed in a compensatory manner during infection of A. castellanii. As
a new means of uncovering important secreted proteins, we identified T2S substrates
whose level of gene transcription is upregulated during infection of amoebas. We
harvested wild-type strain 130b bacteria from both infected A. castellanii and
exponential-phase buffered yeast extract (BYE) cultures, isolated RNA, and used quan-
titative reverse transcriptase PCR (qRT-PCR) to compare gene expression levels in
intracellular versus extracellular bacteria. Since past studies identified some infectivity
factors as being upregulated during the stationary phase (32), we also analyzed
expression in stationary-phase cultures. Whereas five of the secreted-protein genes
showed no change in expression in comparisons of log-phase versus stationary-phase
bacteria, six others, along with the non-T2S csrA gene (33), were downregulated during
the stationary phase (Fig. 1A, left). In contrast, eight other substrate genes, along with
non-T2S flaA (32), had or trended toward increased expression in stationary phase
(Fig. 1A, right). We also saw that the expression levels of genes encoding the T2SS
apparatus were unchanged or downregulated in the stationary phase (Fig. 1A, left).
Analyzing intracellularly grown bacteria, we found that 8/19 secreted-protein genes,
along with lspF, which is representative of the T2SS apparatus, were expressed at a level
that was equal to or slightly less than that seen in broth-grown bacteria (Fig. 1B, left).
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FIG 1 Relative expression levels of genes encoding type II-secreted proteins (effectors) in wild-type L. pneumophila grown in
broth or within amoebas and human macrophages. (A) Gene expression within wild-type 130b bacteria grown in BYE broth
to the exponential phase (E phase) or stationary phase. qRT-PCR data are presented as means with standard errors of results
from three independently grown cultures, with expression in the stationary phase normalized to expression in the E phase in
broth. (B to D) Gene expression within 130b bacteria obtained from infected A. castellanii (B) or N. lovaniensis (C) at 44 h
postinoculation or from infected human U937 macrophages (D) at 12 h postinoculation. qRT-PCR data are presented as means
with standard errors of results from three independent infections (n  3 each), with the intracellular expression normalized
to the E phase in broth. Dashed lines indicate the customary 1.5-fold up- and/or downregulation threshold of biological
interest. Asterisks indicate significant differences with 1.5-fold change relative to the E phase (*, P  0.05; **, P  0.01; ***,
P  0.001 [one-sample t test]).
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Eight other substrate genes were upregulated ~2-fold in intracellular bacteria (Fig. 1B,
middle). Most notably, lapA, lapB, and plaC displayed 5- to 8-fold-higher levels in bacteria
from within amoebas (Fig. 1B, right), suggesting that aminopeptidases LapA and LapB,
which share 42% identity (30), and acyltransferase PlaC (34) are very important during
intracellular growth.
When we examined, in a similar way, gene expression in a plaCmutant (NU420) (23),
we detected an even higher level of expression of lapA and lapB, while the expression
levels of other T2S genes were unchanged or slightly decreased (Fig. 2A). In contrast,
when we assayed transcript levels in a lapA lapB mutant (NU324) (30), there was a
further heightening in levels of plaC mRNA (Fig. 2B). We also detected an increase in
celA transcription in the lapA lapB mutant (Fig. 2B), but, when we examined expression
in a celA mutant (NU353) (29), there was no compensatory increase in expression of
lapA or lapB or of any other genes (Fig. 2C). These data suggested that the intracellular
role(s) of LapA/LapB might be functionally compensatory with respect to that of PlaC,
such that when the aminopeptidases are absent there is an increase in acyltransferase
levels and vice versa. When the plaCmutant and lapA lapBmutant were grown in broth,
no compensatory changes in expression were seen (Fig. 2D), implying that the func-
tional redundancy between PlaC and LapA/LapB may be specific to intracellular growth.
Double mutants reveal key roles for LapA and PlaC in infection of A. castellanii.
We previously observed that neither plaC mutant NU420 nor lapA lapB mutant NU324
FIG 2 Relative expression levels of genes encoding type II-secreted protein effectors in plaC mutant, lapA lapB mutant,
and celA mutant bacteria grown in A. castellanii or in broth. (A to C) Gene expression within wild-type strain 130b (WT)
versus plaC mutant NU420 (A), WT versus lapA lapB mutant NU324 (B), or WT versus celA mutant NU353 (C) obtained from
infected A. castellanii at 44 h postinoculation. qRT-PCR data are represented as means with standard errors of results from
three independent infections (n  3 each), with expression normalized to the exponential (E) phase in broth. Asterisks
indicate significant differences with 1.5-fold change in expression relative to the WT (*, P  0.05 [Student’s t test]). (D)
Gene expression in WT and lapA lapB mutant NU324 (left) or plaC mutant NU420 (right) during E phase in broth. Data are
presented as means with standard errors of results from three independent cultures (n  3), with expression normalized
to the WT results.
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is impaired for infection of A. castellanii (23, 30). Given our transcriptional data, we
posited that a lapA plaC mutant, a lapB plaC mutant, and/or a lapA lapB plaC mutant
might be impaired for infection due to the combined loss of two or more functionally
redundant genes. Thus, we made double and triple mutants, and after observing their
capacity to grow typically in BYE medium and survive normally in conditioned amoebal
medium (see Fig. S1A and B [left panels] in the supplemental material), we tested them
for infection of A. castellanii. Whereas the lapB plaC mutant (NU433) grew similarly to
the wild type (Fig. 3A), the lapA plaC mutant (NU435) displayed an ~50-fold defect in
infection (Fig. 3B). The lapA lapB plaC mutant (NU436) was no more defective than
the lapA plaC mutant (Fig. 3B). Since lapA and plaC are monocistronic (Fig. S2A and B),
the mutant defect was likely due to loss of lapA and plaC rather than polarity on
downstream genes. When lapA was reintroduced into the lapA plaC mutant, there was
restoration of infection (Fig. 3C), confirming the role of LapA. Similarly, the lapA plaC
mutant was complemented by reintroduction of plaC (Fig. 3D), affirming the role of
PlaC. Thus, we extended our transcriptional analysis of intracellular legionellae to
include N. lovaniensis (Fig. 1C). Again, we saw that lapA, lapB, and plaC were upregu-
lated (Fig. 1C, right). legP and map were also notably upregulated (Fig. 1C, right).
Previously, we determined that the lapA lapB mutant is not impaired for infection of
N. lovaniensis, whereas the plaC mutant has an ~10-fold defect (23). Given the tran-
scription data, we compared the lapA lapB plaC mutant and plaC mutant for infection
of N. lovaniensis, to possibly uncover another role for LapA (or LapB). However, the
triple mutant was no more impaired than the single mutant (Fig. S3A). A like result was
attained when we tested mutants in V. vermiformis (Fig. S3B). When analysis was
expanded to include infected macrophages (Fig. 1D), lapA and lapB appeared to be
FIG 3 Intracellular infection of A. castellanii by L. pneumophila wild-type, lapB plaC mutant, lapA plaC mutant, and lapA lapB plaC
mutant strains. (A and B) A. castellanii amoebas were infected with either wild-type strain 130b (WT) and lapB plaC mutant NU433 (A)
or WT, lapA plaC mutant NU435, and lapA lapB plaC mutant NU436 (B). At the indicated times, net bacterial growth was determined
by plating for CFU counts. Data are presented as means with standard errors of results from three independent experiments (n  3
each). Tx/T0, determination time versus time 0. (C and D) Amoebas were infected with WT, lapA plaC mutant NU435, and
complemented mutant NU435 containing plasmid-carried lapA (C) or plasmid-carried plaC (D). Bacterial growth data are presented as
means with standard deviations of results from four infected wells and are representative of three independent experiments. Asterisks
indicate significant differences in CFU recovery between a mutant and the WT or its complemented derivative (*, P  0.05; **, P 
0.01; ***, P  0.001 [Student’s t test]). ns, not significant.
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among the most highly upregulated genes (right), whereas the change seen with plaC
was modest (middle). Since the lapA lapB mutant and plaC mutant are not impaired in
U937 cells (30, 34), we compared the lapA lapB plaC mutant to the wild type with
respect to infection of macrophages. However, no new mutant phenotype was de-
tected (Fig. S3C). Thus, though lapA and plaC expression was upregulated upon
Legionella growth in two hosts, the compensatory link between LapA and PlaC was
detected only in A. castellanii. Our mutant analysis, which was based on transcript data,
uncovered a role for PlaC in infection of A. castellanii, expanding the idea of the
protein’s importance beyond its role in infection of V. vermiformis and N. lovaniensis
(23). A glycerophospholipid-cholesterol and -ergosterol acyl-transferase that has phos-
pholipase A and lysophospholipase A activities, PlaC has been well studied biochem-
ically (34, 35). More importantly, our transcriptional and mutational analyses revealed,
for the first time, a role for the LapA aminopeptidase in an intracellular infection event;
thus, we focused our next efforts on defining the biochemical, structural, and phylo-
genetic traits of LapA.
LapA is a protease-activated, broad-spectrum aminopeptidase. Past work found
that LapA is active against leucine, phenylalanine, and tyrosine aminopeptides, based
on the ability of wild-type supernatants but not lapA mutant supernatants to cleave
those substrates (30). LapA is annotated as a leucine aminopeptidase, and the Merops
database assigns LapA as a member of the M28 family of peptidases (subfamily E) (28,
30, 36). We more completely defined the specificity of LapA by testing wild-type, lspF
mutant, and lapA mutant supernatants against additional aminopeptides. Wild-type
samples had activity against alanine, aspartate, glycine, isoleucine, lysine, methionine,
serine, and valine aminopeptides, in addition to leucine and phenylalanine aminopep-
tides (Fig. 4A). They had no activity against proline- or glutamate-containing substrates.
The lspF mutant lost activity against aspartate, isoleucine, leucine, lysine, methionine,
phenylalanine, and valine substrates but showed normal activity against alanine,
glycine, and serine aminopeptides (Fig. 4A). Thus, 7/10 of the activities are mediated by
T2S. The lapA mutant lacked activity against aspartate, isoleucine, methionine, and
valine aminopeptides and cleaved alanine, glycine, lysine, and serine substrates
(Fig. 4A). As described before (30), the mutant lacked activity against leucine and
phenylalanine aminopeptides (Fig. 4A). When the complemented lapA mutant was
examined, we saw restoration of the six activities that were lacking in the mutant
(Fig. 4A). The complement trended toward elevated levels of activity against alanine
and serine aminopeptides (Fig. 4A), suggesting that increased amounts of LapA might
cleave additional substrates.
To confirm the activities of LapA, we purified recombinant LapA-His6-tagged protein
containing 378 amino acids of the mature lapA product (minus the 23-residue signal
sequence). As expected, purified LapA had activity against leucine, valine, isoleucine,
aspartate, methionine, and phenylalanine aminopeptides, with its activity being
greatest against the leucine substrate (Fig. 4B). LapA lacked activity against proline,
glutamate, and glycine, compatible with supernatant tests. Although assaying of
supernatants had not revealed LapA-dependent cleavage of alanine, lysine, and serine
aminopeptides, due to the presence of LapB and a T2S-independent factor (Fig. 4A)
(30), the testing of purified enzyme affirmed LapA’s ability to cleave these substrates
(Fig. 4B). Combining these data with past results (30), we conclude that LapA is active
against10 substrates. Most substrates had nonpolar, amino acid targets, but, given its
cleavage of aspartate, lysine, serine, and tyrosine aminopeptides, LapA has rather broad
activity (37, 38). Typically of a member of the M28 family (39), LapA was inhibited by
bestatin (Fig. S4A).
LapA was predicted to contain an N-terminal, “protease-associated” (PA) domain,
which in some M28 peptidases is necessarily excised in order to release a C-terminal
peptidase domain (40, 41). That LapA might be processed is suggested from our prior
two-dimensional (2-D) PAGE analysis of supernatants, which had detected truncated
forms of LapA (28). To determine if processed LapA has activity, we purified a version
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of LapA that was missing the putative PA domain and repeated the enzyme assays.
Truncated LapA had activity against the same substrates that had been cleaved by
full-length LapA, with leucine aminopeptide remaining as the favored substrate
(Fig. 4C). Interestingly, the activity against methionine aminopeptide and, to a lesser
extent, the phenylalanine aminopeptide was elevated, whereas the activities against
the other seven substrates were similar or slightly decreased (Fig. 4B and C). These data
indicate that the removal of the PA domain of LapA, though not required, yields an
enzymatically active protein. Also, full-length LapA and truncated LapA may have
different substrate preferences.
We posited that the T2SS-dependent ProA protease might be cleaving secreted
LapA into its N-terminal PA domain and C-terminal peptidase domain. ProA is the major
secreted protein of L. pneumophila and is known to cleave other exoproteins (19, 35, 42,
FIG 4 Aminopeptidase activities from L. pneumophila culture supernatants and purified recombinant LapA. Filter-sterilized supernatants from late-exponential-
phase broth cultures of wild-type 130b (WT), lapA mutant NU320 (lapA), complemented lapA mutant NU320 containing plasmid-carried lapA (lapA/lapA), and
lspF mutant NU275 (lspF) were assayed for activity directed toward aminopeptidase substrates, with the N-terminal amino acid (AA) residue given. (A) Changes
in background-adjusted absorbance at OD405 for the AA–p-nitroanilide substrates or fluorescence (expressed in relative fluorescence units [RFU]) for the
AA–-naphthylamide substrates were monitored kinetically over 2 h. Data are presented as means with standard errors of results from three independent
experiments (n  3 each). Asterisks indicate significant reductions in activity of a mutant relative to the WT (*, P  0.05; **, P  0.01; ***, P  0.001 [Student’s
t test]). (B and C) Strains with purified, full-length LapA (FL-LapA) (B) or LapA missing its N-terminal PA domain (ΔN-LapA) (C) were incubated for 2 h at 37°C
with various AA–p-nitroanilide substrates (left panels) or AA–-naphthylamide substrates (right panels), and the levels of molar activity were determined
(y axes). The relative activities against the various substrates are displayed above each bar, with the level of activity directed toward Leu-pNA (B and C, left)
or toward Phe-NA (B and C, right) arbitrarily set to 100. ND, not detected. Data are presented as means with standard errors of results from two independent
experiments.
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43). Hence, we incubated recombinant LapA, with its His6 tag N terminal to its PA
domain, along with supernatants (diluted 1/10) obtained from the wild-type 130b
strain, the lspF mutant, or the proA mutant, and assayed for the cleavage of LapA
by PAGE and Coomassie staining (Fig. 5A). Wild-type supernatants rapidly cleaved the
~44-kDa LapA, resulting in the appearance of an ~35-kDa C-terminal portion, an
~13-kDa PA domain, and smaller cleavage/degradation products. However, proA mu-
tant supernatants exhibited no evidence of cleavage over 2 h of incubation, appearing
to be equivalent in that respect to the BYE medium control (Fig. 5A). The lspF mutant
supernatants were also deficient for activity, although cleavage products did appear,
most likely due to some release of ProA as a result of cell lysis. Compatibly with these
data, purified LapA treated with (1/10-diluted) wild-type supernatants, but not proA
mutant supernatants or BYE medium, cleaved methionine aminopeptide (Fig. 5B). Thus,
we infer that ProA cleaves and activates LapA. Interestingly, when purified LapA was
mixed for 1 h with undiluted rather than diluted supernatants, ProA-independent
cleavage of LapA was seen (Fig. 5C). When immunoblots were used to examine the
effect of undiluted proA mutant supernatants, the low-level cleavage event (the ap-
pearance of His-tagged PA) was detected after 5 min (Fig. 5D). However, undiluted proA
mutant supernatants retained activity against leucine and methionine aminopeptides
(Fig. 5E). Incidentally, the proA mutant supernatants still lacked activity against lysine
aminopeptide, a LapB substrate (Fig. 5E), and ProA-dependent cleavage of LapB was
observed on stained gels (Fig. 5F). Overall, these data showed that ProA is mainly
responsible for activation of LapA but that LapA can also be cleaved, albeit to a lesser
extent, by another secreted factor.
The structure of LapA. To determine how LapA provides its broad specificity, we
began structural studies of recombinant LapA. Crystals were readily obtained, and its
structure was determined by molecular replacement, using the coordinates of LapB
(PDB code: 5GNE) (41) as the search model, and electron density maps were refined to
1.9 Å. The structure of LapA contains two molecules in the asymmetrical unit, and all
residues could be built except for the N-terminal His tags and residues within the
interdomain linkers (residues 82 to 101) that connect the PA domain (residues 1 to 81)
and aminopeptidase domains (residues 102 to 378). The PA domain is formed of four
helices and three -strands, and the aminopeptidase domain has nine helices and
seven -strands. Although LapA was purified as a monomer, in our structure, the PA
domain of one chain was associated with the aminopeptidase domain of an adjacent
chain, which formed a domain-swapped dimer (Fig. 6A). The domain-swapped mono-
mers were essentially identical, with a root mean square deviation (RMSD) over C
atoms of 0.083 Å (without linkers), although variations were seen within the interdo-
main sequence. As an M28 family metalloprotease, the peptidase domain of LapA binds
two Zn ions in its active site, which are coordinated by the conserved residues His194,
Asp207, Glu241, Glu242, Asp269, and His347 and one water molecule (Fig. 6B). Drawing
on structures of aminopeptidases from Streptomyces griseus (PDB code: 1F20) (44) and
Aeromonas proteolytica (PDB code: 1XRY) (45), the main determinant of specificity in
this class of enzyme is a binding pocket directly adjacent to the active site, and in LapA,
this is formed from the side chains of Asp269, Met270, Phe285, Cys314, Cys318, Phe333,
Cys335, Phe339, and His342 and from the backbone of Ser319, Thr337, and Ser338
(Fig. S4B). This creates a relatively deep hydrophobic cavity, which can readily accom-
modate aromatic and aliphatic residues (Fig. 6C; see also Fig. S4B). In our structure of
LapA, the PA domain covers the active site and substrate-binding pocket (Fig. S5) and
thus represents the proenzyme form of LapA. A ring of predominantly hydrophobic
residues on the surface of the enzymatic domain (Trp170, Leu198, Asp199, Tyr316,
Phe339, His342, His347) provides a platform for the PA domain to dock, and this is
mediated through its -1 strand (Glu7), 2-helix (Ser39, Glu43, Thr46, Asp50), 2-3
linker (His56, Phe57, Asn59), and 3-helix (His62).
LapA promotes nutrient acquisition during infection. Given the enzymatic ac-
tivity of LapA, which was revealed by structural analysis, we posited that LapA pro-
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FIG 5 Effect of type II-secreted factors on LapA and LapB processing and activity. (A and B) Purified, full-length LapA (FL-LapA) (Input) was incubated at 37°C
for the indicated times with either BYE medium or 1/10-diluted supernatants (sup) obtained from late-exponential-phase broth cultures of wild-type strain 130b
(WT), lspF mutant NU275 (lspF), or proA mutant AA200 (proA) and then processed by SDS-PAGE followed by Coomassie staining for total protein detection (A)
or incubated with methionine aminopeptidase substrate in order to assess LapA activation (B). Arrows to the left of the gel image in panel A denote the
migration position of FL-LapA, LapA missing its N terminus (ΔN-LapA), the PA domain of LapA (PA domain), and smaller cleavage products (PA domain=). The
identity of the minor bands that were present within the input material (including one that appears to nearly comigrate with ΔN-LapA) and were maintained
during incubation with the BYE medium or culture supernatants is unknown, but they likely represented breakdown products of the recombinant LapA. The
migration of molecular mass markers (in kilodaltons) is also denoted to the left of the gel in panel A. Enzyme activity data in panel B are presented as means
with standard errors of results from three independent experiments (n  3 each). Asterisks indicate significant increases in activity relative to t  5 min (*, P 
0.05 [Student’s t test]). ND, not detected. (C and D) Purified FL-LapA was incubated at 37°C for the indicated times with either BYE medium or undiluted culture
supernatants obtained from WT or proAmutant cultures and then processed for SDS-PAGE and Coomassie staining (C) or immunoblot analysis (IB) using anti-His
antibodies directed against the hexahistidine tag embedded at the start of the PA domain (D). Arrows to the right side of the images in panels C and D denote
the migration position of FL-LapA, ΔN-LapA, and the PA domain fragments, with the migration of the molecular mass markers denoted as well. Although the
samples examined in panel D were on the same gel, they were not in adjacent lanes; therefore, we cropped out the intervening lanes that were not pertinent
to the analysis. Data in panels C and D are representative of results of three and two experiments, respectively. (E) Filter-sterilized supernatants from
late-exponential-phase broth cultures of wild-type 130b (WT), lapA mutant NU320 (lapA), and proA mutant AA200 (proA) were assayed for activity directed
toward aminopeptidase substrates, with the N-terminal amino acid (AA) residue given. Changes in background-adjusted absorbance at OD405 for the
AA–p-nitroanilide substrates were monitored kinetically over 2 h. Data are presented as means with standard errors of results from three independent
experiments (n  3 each). Asterisks indicate significant reduction in activity of a mutant relative to the WT (*, P  0.05; **, P  0.01; ***, P  0.001 [Student’s
t test]). (F) Purified, full-length LapB (FL-LapB) (Input) was incubated at 37°C for the indicated times with either BYE medium or undiluted supernatants obtained
from late-exponential-phase broth cultures of wild-type strain 130b (WT), lspF mutant NU275 (lspF), or proA mutant AA200 (proA) and then processed by
SDS-PAGE followed by Coomassie staining for total protein detection. Arrows to the left of the gel image denote the migration position of FL-LapB and of LapB
missing its N terminus (ΔN-LapB). The migration of molecular mass markers (in kilodaltons) is also denoted to the left of the gel. Data are representative of
results from 3 independent experiments.
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motes L. pneumophila growth in A. castellanii by cleaving aminopeptides to release
amino acids for uptake by the parasite. Thus, we asked if addition of a cocktail of amino
acids to the Legionella–Acanthamoeba coculture could rescue growth of the lapA plaC
mutant. To facilitate this experiment, we employed an amino acid cocktail (aspartate,
alanine, glutamate, asparagine, glycine, serine, and proline) that was previously used to
rescue the growth of a L. pneumophilamutant that was starved due to its lack of a T4SS
effector (46). Thus, we used a reagent that was not inhibitory to L. pneumophila or its
host. Moreover, the aspartate, alanine, and serine in the cocktail are predicted prod-
ucts of LapA activity (Fig. 4). Whereas amino acid supplementation had no effect on
wild-type growth, it increased lapA plaC mutant numbers at 72 h postinoculation, and
the results trended toward increases at 48 h (Fig. 7A). Thus, amino acid supplementa-
FIG 6 Overall structure of LapA. (A) The LapA domain-swapped dimer of the asymmetrical unit is
presented as a cartoon with zinc ions drawn as gray spheres. (B) Active-site residues are shown as sticks,
and zinc ions (gray) and water molecules (red) are drawn as spheres. (C) Electrostatic surface of the LapA
aminopeptidase domain with active-site zinc ions as gray spheres (left). The electrostatic surface of LapA
superimposed with (middle) the S. griseus aminopeptidase/L-leucine complex (PDB code: 1F2O) (48) or
(right) the A. proteolytica aminopeptidase/bestatin complex (PDB code: 1XRY) (49), indicating potential
binding of substrate amino acids, is shown. Leucine and bestatin are shown as spheres.
FIG 7 Intracellular infection of A. castellanii by the L. pneumophila wild-type strain, lapA plaCmutant, and
lspF mutant in the presence of added amino acids. A. castellanii amoebas were infected with wild-type
strain 130b (WT), lapA plaC mutant NU435, or lspF mutant NU275, and, at the indicated times, bacterial
growth was determined. Where indicated, the medium in the infected wells was supplemented with 1
mM excess amino acids (AA) for the duration of the experiment. Growth data are presented as means
with standard errors of results from three independent experiments (n  3 each). Asterisks indicate
significant differences in CFU recovery between strains under the given conditions (*, P  0.05; **, P 
0.01 [Student’s t test]). ns, not significant.
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tion phenocopied the complementation results (Fig. 3C). The supplementation did not
rescue the lspF mutant (Fig. 7B), which is compatible with this mutant lacking many
exoproteins. Since neither the wild type nor the T2SS mutant was affected by addi-
tion of amino acids, the rescue of the lapA mutant was not a nonspecific effect on
A. castellanii or L. pneumophila. Thus, the LapA mutant’s infection defect is tied to its
loss of enzyme activity. Given that LapA, PlaC, and amino acid acquisition does not fully
account for the1,000-fold defect observed upon complete loss of T2S (23), we sought
additional secreted proteins that promote infection of amoebas.
Proteomic and mutational analyses identified NttD as a novel T2SS-dependent
exoprotein that also promotes infection of A. castellanii. We next studied a 41-kDa
protein that was previously detected in supernatants of L. pneumophila wild-type strain
130b grown in BYE broth but was absent in similarly derived supernatants of an lspF
T2S mutant (28). Inspection of the 130b genome (47) revealed that the T2SS-dependent
protein is encoded by open reading frame (ORF) L. pneumophila lpw10421, the second
gene in a four-gene operon (Fig. S2C). Given our proteomics data and the bioinformatic
analysis that is to follow, we named lpw10421 nttD, for novel type two secreted protein
D, following the nomenclature used to denote nttA, nttB, and nttC (23, 24). NttD is not
annotated but is noted to have domain-of-unknown-function 4785. An unpublished
crystal structure for NttD from L. pneumophila strain Philadelphia-1 has been deposited
by others in the Protein Data Bank (PDB code: 4KH9). NttD is a mainly -strand protein,
and analysis using the PISA server (48) indicated that it exists as a dimer (Fig. S6A),
although we detected equilibrium between the monomer and dimer in solution
(Fig. S6B). Each chain is made of three unique domains, with the N-terminal domain
mediating dimerization. While tertiary-structure analysis using the Dali server (49)
detected no homologies for the N-terminal domain (no Z score of 8), the C-terminal
domain shared features with glycosidases. Yet when we tested purified protein and
concentrated supernatants against glycosidase substrates, no activity was seen. In
order to discern a role for NttD, we made a mutant of 130b inactivated for nttD (NU431).
The mutant grew in BYE broth like the parental 130b strain (Fig. S1A, right), indicating
that NttD is not required for extracellular survival, at least under standard conditions.
From examination of BYE supernatants, the mutant had normal levels of phosphatase,
protease, and lipase activities (not shown), indicating that loss of NttD does not cause
a general defect in T2S (24, 50). Whereas the intracellular replication of the nttDmutant
was not affected in the human U937 cell macrophages and Naegleria and Vermamoeba
amoebas (Fig. 8A to C), it was impaired for infection of A. castellanii (Fig. 8D). At 48 and
72 h postinoculation, the NU431-infected acanthamoebae yielded ~30-fold-fewer le-
gionellae. When infections were done in a transwell apparatus, such that bacteria were
prevented from contacting host cells, the wild type and the mutant, though not
growing, survived similarly (Fig. S1B, right), indicating that the reduced recovery of the
mutant from the coculture was a result of defective infection rather than of impaired
survival in the medium. When we tested a second nttD mutant (NU432) for infection of
A. castellanii, the same defect was seen (not shown), implying that the loss of infectivity
was due to the mutation in nttD rather than to a second-site mutation. Because a
wild-type level of growth was achieved upon reintroduction of nttD into mutant NU431
(Fig. 8E), we concluded that NttD is required for infection of A. castellanii. Together,
these data document NttD as a novel, T2SS-dependent exoprotein that promotes
L. pneumophila infection of A. castellanii, thereby enhancing the range of Legionella in
aquatic habitats. Discovering substantial roles for NttD, PlaC, and LapA in L. pneumo-
phila infection of A. castellanii, we pondered to what degree these proteins account for
the role of T2SS in infection. Thus, we tested a new mutant (NU441) that lacks lapA,
plaC, and nttD. The triple mutant had a sizeable defect that went from ~90-fold at 48 h
postinoculation to ~130-fold at 72 h (Fig. 8F). This defect was greater than that of the
nttDmutant and lapA plaCmutant (Fig. 8F), indicating that NttD and LapA/PlaC operate
in distinct pathways. The lapA plaC nttD mutant’s defect did not fully recapitulate the
lspF mutant’s defect (Fig. 8F), indicating that there are additional T2S-dependent
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proteins that contribute to intracellular infection. However, the NttD, LapA, and PlaC
data do explain, to a significant degree, the role of T2S in infection of A. castellanii.
Bioinformatic analysis revealed distinctive distribution patterns for nttD-,
plaC-, and lapA-related genes within and outside the Legionella genus. All se-
quenced L. pneumophila strains and all of the 40 other sequenced species of Legionella
have complete T2SSs (see Table S1 in the supplemental material). Therefore, we
performed BLAST analyses to discern the species- and genus-wide distribution of nttD,
plaC, and lapA. The nttD gene was in all L. pneumophila strains, and an nttD-like gene
was in 36/40 Legionella species (Fig. 9; see also Table S2A). On the basis of the
distribution of nttD-like genes across the phylogenetic tree, nttD was found to be an
ancestral gene that, though largely conserved, has been lost twice (Fig. 9). Further
BLAST analysis found that NttD shares relatedness to hypothetical proteins in 9
genera of gammaproteobacteria and in one genus of deltaproteobacteria (Table 1).
Similarly to nttD, plaC was conserved in the L. pneumophila species (Table S2B). A
plaC-like gene was evident in 32 other Legionella species (Fig. 9; see also Table S2B). The
8 remaining species lacked a plaC-like gene, indicating that the gene occurs in ~80% of
species. We surmise that plaC, like nttD, is an ancestral gene that, though reasonably
conserved, has been lost twice (Fig. 9). Like nttD, plaC was lost prior to emergence of
the adelaidensis-londiniensis-oakridgensis clade. Yet plaC appears to have also been lost
prior to the advent of the feeleii-micdadei-drozanskii clade, resulting in a lower level of
conservation than was determined for NttD (Fig. 9). Looking beyond Legionella, we
found homologues of PlaC in genera of gammaproteobacteria, although these genera
were different from those that had NttD homologues (Table 2). Interestingly, most
non-Legionella homologues of PlaC, including the closest homologues, were in Cyano-
bacteria, a distant phylum that does not have a canonical T2SS (Table 2) (13). BLAST
revealed that lapA occurs in all L. pneumophila strains (Table S2C). lapA-like genes were
FIG 8 Intracellular infection of macrophages and amoebas by the L. pneumophila wild-type strain, an nttD mutant, a complemented nttD mutant, and a lapA
plaC nttD mutant. (A to E) U937 cells (A), N. lovaniensis (B), V. vermiformis (C), and A. castellanii (D and E) were infected with wild-type strain 130b (WT), nttD
mutant NU431, or complemented nttD mutant NU431 containing plasmid-carried nttD, and, at 0, 24, 48, and 72 h postinoculation, CFU levels in the infected
wells were assayed. Bacterial growth resulting from intracellular infection is expressed as the ratio of the CFU level at t  24, 48, or 72 h to the CFU level at
t  0. Data in panels A to D are presented as means with standard errors of results from at least three independent experiments (n  3). Data in panel E are
presented as means with standard deviations of results from four infected wells and are representative of three independent experiments. Asterisks indicate
significant differences in the levels of CFU recovery between the mutant and the WT or the complemented mutant (*, P  0.05; **, P  0.01; ***, P  0.001
[Student’s t test]). (F) Amoebas were infected with the WT or lapA plaCmutant NU435, nttDmutant NU431, lapA plaC nttDmutant NU441, or lspFmutant NU275,
and, at the indicated times, net bacterial growth was determined. Data are presented as means with standard errors of results from three independent
experiments (n  3 each). The lapA plaC nttD mutant displayed significantly reduced CFU recovery compared to the WT, the lapA plaC mutant, and the nttD
mutant at 48 and 72 h postinoculation (P  0.05 [Student’s t test]). The lspF mutant exhibited an even great reduction in growth compared to the WT, the lapA
plaC mutant, and the nttD mutant at 24, 48, and 72 h (P  0.01 [Student’s t test]).
White et al. ®
March/April 2018 Volume 9 Issue 2 e00528-18 mbio.asm.org 12
 o
n








in 38 of the other species of Legionella (Fig. 9; see also Table S2C). Only L. maceachernii
and L. londiniensis did not carry a lapA-like gene, due to two “recent” gene loss events.
Thus, lapA is in ~95% of species, indicating that it is an ancestral gene that is even more
prevalent than nttD or plaC (Fig. 9). LapB, though conserved within the L. pneumophila
species (Table S2D), is present in only 12% of non-pneumophila species (Fig. 9; see also
Table S2D). Seemingly, lapB is a recent gene acquisition, coincident with emergence of
the clade containing L. pneumophila (Fig. 9). We also wondered about the prevalence
of ProA, the T2SS-dependent protease that activates LapA and PlaC (Fig. 5) (35), and
found that proA was 100% conserved (Fig. 9). Returning to the distribution of LapA-like
FIG 9 Distribution of genes encoding key type II-secreted proteins within the Legionella genus. Gain and loss events pertaining to
genes encoding type II-secreted NttD, LapA, LapB, PlaC, and ProA were modeled on a maximum-likelihood tree of 41 Legionella
species, which was constructed based on the protein sequence encoded by 78 nearly universal genes (9). Colored circles and arrows
indicate a gene gain event (upward-pointing arrow) or loss event (downward-pointing arrow) based on maximum parsimony, and
colored cells (right) indicate the presence of nttD, lapA, lapB, plaC, and proA within a given species.
TABLE 1 BLAST results for NttD outside the Legionella genusa
Organismb I, S, Cc E value Accession no. Classification
Dyella japonica 25, 45, 89 1E22 WP_035323882.1 Gammaproteobacteria
Oleiagrimonas soli 25, 44, 80 2E21 WP_043100684.1 Gammaproteobacteria
Nannocystis exedens 23, 43, 80 1E19 WP_096328563.1 Deltaproteobacteria
Arenimonas oryziterrae 24, 41, 85 3E18 WP_022968800.1 Gammaproteobacteria
Kangiella aquimarina 26, 44, 72 2E16 WP_018624440.1 Gammaproteobacteria
Lysobacter capsici 23, 40, 86 7E13 WP_082723375.1 Gammaproteobacteria
Microbulbifer donghaiensis 24, 46, 80 2E12 WP_073272160.1 Gammaproteobacteria
Teredinibacter turnerae 25, 45, 80 1E11 WP_018414733.1 Gammaproteobacteria
Rhodanobacter spathiphylli 22, 41, 83 1E11 WP_007808810.1 Gammaproteobacteria
Stenotrophomonas maltophilia 22, 38, 78 4E10 WP_042612098.1 Gammaproteobacteria
aAnalysis of non-Legionella homologues was done with the exclusion of hits from the Legionella genus only
with homologues predicted using an E-value cutoff of 4  1010 and an alignment length of at least 65%
(80).
bOnly the top representative species per genus is given, based on the closest homology with NttD.
cI, percent identity; S, percent similarity; C, percent coverage.
Legionella Type II Secretion ®
March/April 2018 Volume 9 Issue 2 e00528-18 mbio.asm.org 13
 o
n








proteins but looking beyond Legionella, BLAST analysis found that LapA’s closest
prokaryotic homologues occur in betaproteobacteria (Table 3). This pattern of distri-
bution of non-Legionella homologues was very different from that of NttD and PlaC,
which included primarily gammaproteobacteria or cyanobacteria and no betaproteo-
bacteria (Tables 1 and 2). Even more interestingly, the closest relative, which had 41%
identity and 60% similarity with LapA, was an aminopeptidase of A. castellanii (Table 3).
Other eukaryotic LapA-like proteins were in fungi, and in many cases, they were closer
to LapA than the prokaryotic homologues (Table 3). Thus, LapA has strong eukaryotic-
protein-like traits.
DISCUSSION
The experimental data presented increase our understanding of T2S and host-
parasite interactions in multiple ways. With the definition of NttD and LapA as major
potentiators of infection of A. castellanii, the number of T2S effectors confirmed as
being involved in infection of amoebas rises to seven (23, 24, 30, 31). Thus, approxi-
mately one-third of the known effectors are required for infection (13), implying that
TABLE 2 BLAST results for PlaC outside the Legionella genus
Organisma I, S, Cb E value Accession no. Classification
Anabaena cylindrical 28, 47, 69 5E32 WP_015214616.1 Cyanobacteria
Cylindrospermum stagnale 27, 44, 70 4E29 WP_015210343.1 Cyanobacteria
Endozoicomonas arenosclerae 29, 43, 95 3E27 WP_062262828.1 Gammaproteobacteria
Anabaenopsis circularis 23, 41, 72 1E26 WP_096581537.1 Cyanobacteria
Fischerella muscicola 26, 42, 68 6E26 WP_051035591.1 Cyanobacteria
Tolypothrix bouteillei 25, 43, 69 7E26 WP_038073042.1 Cyanobacteria
Chlorogloeopsis fritschii 27, 42, 71 9E26 WP_016872501.1 Cyanobacteria
Mastigocladopsis repens 28, 43, 69 1E25 WP_033366504.1 Cyanobacteria
Scytonema millei 25, 42, 75 3E25 WP_069349443.1 Cyanobacteria
Hassallia byssoidea 26, 42, 68 2E24 KIF33255.1 Cyanobacteria
aOnly the top representative species per genus is given, based on the closest homology with PlaC. After the
genera listed here, the next seven encoding a PlaC-like protein (E value, 1E18) are five cyanobacteria
followed by two gammaproteobacteria.
bI, percent identity; S, percent similarity; C, percent coverage.
TABLE 3 BLAST results of LapA outside the Legionella genus
Organisma I, S, Cb E value Accession no. Classification
Acanthamoeba castellanii 41, 60, 70 7E65 XP_004341372.1 Eukarya—protozoa
Chromobacterium sphagni 40, 59, 70 2E64 WP_071111733.1 Betaproteobacteria
Chitinimonas koreensis 40, 59, 70 5E64 WP_028447211.1 Betaproteobacteria
Burkholderia thailandensis 39, 59, 69 5E61 WP_019254803.1 Betaproteobacteria
Pseudogulbenkiania ferrooxidans 38, 58, 70 8E61 WP_021478877.1 Betaproteobacteria
Massilia yuzhufengensis 39, 57, 70 2E60 WP_091877370.1 Betaproteobacteria
Pleurotus ostreatus 37, 53, 75 8E60 KDQ28511.1 Eukarya—fungi
Duganella sacchari 33, 53, 92 9E60 WP_072788963.1 Betaproteobacteria
Janthinobacterium agaricidamnosum 37, 57, 72 2E59 WP_038494963.1 Betaproteobacteria
Syncephalastrum racemosum 39, 58, 68 5E59 ORY97700.1 Eukarya—fungi
Coprinopsis cinerea 37, 57, 71 7E59 XP_001831818.1 Eukarya—fungi
Actinomucor elegans 36, 58, 68 9E59 AME15509.1 Eukarya—fungi
Rhizophagus irregularis 36, 57, 69 2E58 ESA22882.1 Eukarya—fungi
Trichosporon asahii 37, 56, 72 7E58 EKD01610.1 Eukarya—fungi
Roseateles aquatilis 38, 56, 70 1E57 WP_088383330.1 Betaproteobacteria
Conidiobolus coronatus 38, 57, 69 1E57 KXN70597.1 Eukarya—fungi
Pseudoduganella violaceinigra 34, 55, 81 3E57 WP_028103074.1 Betaproteobacteria
Cylindrobasidium torrendii 34, 53, 77 3E57 KIY62743.1 Eukarya—fungi
Ulvibacter litoralis 40, 55, 69 3E57 WP_093139368.1 Bacteroidetes
Mucor circinelloides 36, 58, 69 5E57 EPB89639.1 Eukarya—fungi
Schizophyllum commune 36, 55, 69 8E57 XP_003037075.1 Eukarya—fungi
Pseudoalteromonas byunsanensis 36, 56, 79 1E56 WP_070992923.1 Gammaproteobacteria
aOnly the top representative species per genus is given, based on the closest homology with LapA. After the genera listed here, the next 20 encoding a LapA-like
protein (E value, 1E53) are 15 genera of fungi and 1 genus each of betaproteobacteria, gammaproteobacteria, deltaproteobacteria, Actinobacteria, and
Bacteroidetes.
bI, percent identity; S, percent similarity; C, percent coverage.
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intracellular parasitism has played a large role in shaping the T2SS repertoire. That NttD,
along with the previously described NttA and NttC, has a role in amoebal infection and
yet lacks similarity to known enzymes suggests that many T2SS substrates may be
specialized for the intra-amoebal lifestyle (23, 24). Although aminopeptidases in the
M28 family have been linked to T2S and/or virulence (37, 51, 52), the results from this
study of LapA mark the first documentation of a secreted aminopeptidase promoting
an intracellular infection event. Thus, prokaryotic LapA-like proteins (Table 3) may be
facilitating survival for bacteria such as Duganella and Burkholderia spp. that reside in
amoebas (53). In establishing a link between LapA and PlaC, we have also revealed a
unique example of functional redundancy operating during infection. While promoting
growth in A. castellanii, NttD and the combination of LapA and PlaC were not needed
for infection of other amoebas. This highlights how the importance of T2SS substrates
varies in a host-specific fashion; presumably, each amoebal type represents a distinct
environment and, hence, L. pneumophila invokes different exoproteins in order to
efficiently establish its host range. Unlike NttD and LapA, PlaC was critical for infection
of every amoebal host. There are probably commonalties across different amoebas, and
so L. pneumophila repeatedly relies upon some of its effectors to flourish in aquatic
habitats. The finding that ProA processes LapA and LapB adds to past work showing
that ProA cleaves PlaA and PlaC and is required for strain 130b infection of V. vermi-
formis and N. lovaniensis (30, 35, 43). Another study found that a proA (mspA) mutant
of strain JR-32 is impaired for infection of A. castellanii (19). Thus, ProA rivals PlaC in its
broad significance. Although previous studies reported on the transcription of a few
T2S genes (54–56), the current analysis represents the largest assessment of T2S
effector expression by L. pneumophila. After examining 19 genes in two stages of
extracellular growth and in three hosts, it is apparent that secreted-protein genes
exhibit a variety of expression patterns rather than showing similar responses to
conditions. From this, we intuit that the amounts of secreted protein made are
controlled at the level of the individual or of subsets of effector-gene transcription
more than at the level of apparatus gene transcription.
Bioinformatic analyses revealed further insights into T2SS and the origins of its
effectors. Being found in the majority of Legionella species, the genes encoding NttD,
PlaC, and LapA appear to be ancestral genes that underwent only a few loss events
during the evolution of the genus. On the basis of the dispersal of homologues in other
types of organisms, ancestral NttD was likely acquired from related gammaproteobac-
terial species, PlaC from cyanobacterial species, and LapA from protozoa or fungi. ProA
is encoded by another ancestral T2SS gene, but in this case, no loss events were
detected. Unlike NttD, PlaC, LapA, and ProA, LapB was only in the “recent” clade
containing L. pneumophila. We posit that LapB arose from lapA duplication. This is
supported by phylogenetic analysis of LapA and LapB, which form a monophyletic
group exclusive of other bacteria or eukaryotes, and is based on the fact that LapB has
acquired substitutions relative to the ancestral LapA (Fig. 10). Given that NttD, PlaC,
LapA, and ProA promote infection but LapB does not, we speculate that ancestral,
highly conserved T2SS effectors have the greater role in intracellular parasitism. This
evolutionary pattern for T2SS effectors differs from that of most T4SS effectors, which
are distributed in 25% of Legionella species (9).
The activities associated with PlaC and LapA provide hypotheses for how these T2S
substrates promote infection. PlaC not only generates fatty acids but also can modify
lipids within amoebal vacuoles (34, 35). Thus, PlaC may promote intracellular nutrient
acquisition via direct lipid metabolism, or through modification of lipids in LCV mem-
branes, which might in turn influence vesicular trafficking or anchoring of other
effectors. LapA likely promotes replication through its ability to generate amino acids
that are limiting during the intracellular lifecycle. Our analysis found a broad spectrum
of activity for LapA, and we showed that amino acid supplementation rescues the
growth of mutants lacking LapA. Interestingly, the leucine, methionine, isoleucine, and
valine generated by LapA, coupled with arginine produced by LapB (30), account for all
of the amino acids that cannot be synthesized by L. pneumophila or A. castellanii (46).
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It is intriguing to contemplate why LapA and PlaC, two very different exoenzymes,
should overlap in terms of function. In one scenario, L. pneumophila utilizes both amino
acids (generated by LapA) and lipids (generated by PlaC) for nutrition within the LCV.
Thus, a growth defect is revealed only when both LapA and PlaC are absent, depriving
the bacterium of two food sources. Alternatively, changes to LCV membranes mediated
by PlaC might promote the import of nutrients beyond those targeted by LapA. Hence,
without PlaC and LapA, intravacuolar bacteria again lose two food sources. To discern
how PlaC and LapA operate, it would be helpful to learn their locations in the infected
cell. Proteins secreted by T2S, including ProA, can be translocated out of the LCV (57),
and thus, it is possible that LapA or PlaC or both have targets in the host cytoplasm.
Overall, LapA and PlaC modulate different processes and yet accomplish a single task.
With the characterization of LapA, we have a striking example of a eukaryotic-
protein-like, T2SS-dependent exoprotein, indicating that eukaryotic-protein-like effec-
tors of L. pneumophila are not limited to the T4SS (58). LapA was likely acquired through
horizontal gene transfer within A. castellanii or an ancestral protozoan. Indeed, the
top-scoring LapA homologue outside Legionella belongs to A. castellanii and is a
putative aminopeptidase. Also, LapA shares higher-than-average homology to its top-
scoring eukaryotic homologue (41% identity, 60% similarity), compared to the average
levels of identity and similarity of all other (primarily T4SS) eukaryotic-protein-like
FIG 10 Interkingdom phylogenetic tree of LapA-like proteins. A maximum-likelihood tree shows 41 aligned amino acid sequences of
M28 family aminopeptidases. Bootstrap values (from 250 replicates) of 50 are given at the corresponding nodes. Aminopeptidase
Y from Saccharomyces cerevisiae was used as the outgroup. The scale bar indicates the number of amino acid substitutions per site.
Fungi are indicated in red, protozoa in purple, and bacteria in green, with the exception of L. pneumophila proteins, which are
indicated in blue. NCBI accession numbers not listed in Table 3 are noted in parentheses after the respective genus designations.
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proteins of L. pneumophila (34% identity, 52% similarity) (59). Moreover, phylogenetic
reconstruction of aligned amino acid sequences of LapA homologues revealed that
LapA is not descended from other bacteria but shares a common ancestor with
A. castellanii (Fig. 10). Interestingly, the A. castellanii aminopeptidase is secreted (60).
Thus, legionellae benefit from secreting a host-like aminopeptidase as a means of
scavenging limiting amino acids.
The structure of LapA is similar to those of several known aminopeptidases. The Dali
server identified LapB (41) and A. proteolytica Apap (PDB code: 1AMP) (61) as having the
highest tertiary homology (Z scores of 54.6 Å and 45.0 Å, respectively), although this is
concentrated at the peptidase domain (see Fig. S7A in the supplemental material). For
example, the positions of active-site residues in LapA and LapB structures are almost
identical (Fig. S7B), while there is a significant reorganization of helices between PA
domains. This accommodates differences in their substrate-binding pockets, with
LapB’s cavity being wider and more negatively charged (Fig. S7C), compatible with a
preference for positively charged lysine and arginine (30). Often, the role of the PA
domain is to keep an enzyme in an inactive state prior to secretion (62), although for
purified LapA, it did not prevent detection of activity. The effect of the PA domain is
likely due to a transient association between the PA and peptidase domains in LapA, as
we observed a monomeric and domain-swapped form in solution. Although domain
swapping was not seen in the structure of LapB, it dimerizes in solution and its PA
domain does not prevent detection of activity under some conditions (41). The LapA
structure is the fifth structure for a Legionella T2SS effector, joining those of NttD, LapB,
phosphatase Map, and VirK-like Lpg1832 (28, 41, 63–65).
Although the PlaC, LapA, and NttD data explain, to a large extent, the impact of T2S
on L. pneumophila infection of A. castellanii, future work should further define the
Legionella T2SS output. Proteomic assessment of supernatants and subsequent (single)
mutant analysis have heretofore been the means to identifying T2SS-dependent pro-
teins that promote infection (13). These approaches helped reveal the nature of NttD
as a potentiator of infection and will continue to offer new targets for analysis (28). Yet
this strategy clearly failed to reveal the roles that LapA and PlaC have in A. castellanii
infection (23, 30), undoubtedly due to the redundancy that exists between LapA and
PlaC. The new-found importance of these two effectors was uncovered through a
combination of transcriptional and mutational analyses. This approach has four steps:
(i) identification of the genes that are upregulated during wild-type infection of the
host; (ii) examination of the transcript profile of mutants that lack the upregulated
genes, while being alert to compensatory increases in other transcripts; (iii) mutation of
two or more upregulated genes that exhibit a compensatory link; and (iv) testing of
mutants for loss of infection. Our data set predicts more substrates that may promote
infection; e.g., two strongly upregulated genes during infection of A. castellanii and
N. lovaniensis were legP encoding a putative protease and map encoding a phospha-
tase (Fig. 1B and C). Though neither a legP mutant nor a map mutant was impaired for
infection (23), a legP map mutant might be defective. Interestingly, LegP and Map, like
LapA, have eukaryotic-protein-like homologs (23, 28, 64).
MATERIALS AND METHODS
Strains, plasmids, and media. L. pneumophila 130b (ATCC BAA-74) served as the wild type and
parent for all mutants (25). proA mutant AA200, lspF mutant NU275, lapA mutant NU320, lapB mutant
NU322, lapA lapB mutant NU324, celA mutant NU353, and plaC mutants NU367 and NU420 were
described before (14, 15, 23, 29, 30, 66). Newly derived mutants lacking nttD, lapA, or plaC were made
using methods of allelic exchange (23, 25). Complemented mutants were obtained by introducing intact
copies of nttD, lapA, or plaC on a plasmid, analogously to past studies (24). Primers and plasmids used
in mutant and complement constructions are listed in Table S3 in the supplemental material. Legionellae
were routinely grown at 37°C on buffered charcoal yeast extract (BCYE) agar or in BYE broth (25).
Escherichia coli DH5 (Life Technologies) was the host for the recombinant plasmids used in mutant
construction and complementation. E. coli K-12 SHuffle (NEB) was used to get purified protein. E. coli cells
were grown in LB medium. Unless otherwise noted, chemicals were from Sigma.
Infection assays. U937 cells (ATCC CRL-1593.2), A. castellanii (ATCC 30234), V. vermiformis (ATCC
50237), and N. lovaniensis (ATCC 30569) were infected with L. pneumophila as previously described (23).
To assess survival of L. pneumophila in A. castellanii-conditioned media, we inoculated legionellae and
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amoebas on opposite sides of a 0.4-m-pore-size transwell membrane (Corning; catalog no. 3470). To
that end, 1 105 amoebas in 1 ml of protease-peptone-yeast extract (PY) medium (23) were seeded into
24-well plates, and then 1  104 wild-type or mutant bacteria were added in 100 l PY medium to the
transwell support. After periods of incubation, a 10-l aliquot from the upper chamber was plated on
BCYE agar to determine numbers of legionellae. To test the effect of amino acid supplementation on
bacterial growth in A. castellanii, an amino acid cocktail (Lonza; catalog no. 13-114E) was added to the
PY medium, giving 1 mM of each amino acid.
Quantitative reverse transcriptase PCR. qRT-PCR was done as previously described (17). To
monitor L. pneumophila transcription during extracellular growth, RNA was isolated from BYE cultures
using a GeneJET RNA purification kit (Thermo Scientific). To examine bacterial RNA from infected host
cells, U937 cells, A. castellanii, and N. lovaniensis were infected as described above, with the exception
that the inoculation step was facilitated by centrifugation (500  g, 5 min) of bacteria onto the
monolayer, and the infected cells were lysed and processed using the GeneJET kit. Primers RW12 to RW69
(Table S3) used for qRT-PCR were designed using the Primer-BLAST tool at NCBI. lpw00031 (gyrB) and
lpw16991 were used as references to normalize gene expression (67), and changes in expression were
calculated using the threshold cycle (2ΔΔCT) method (68).
Protein purifications. Full-length LapA (FL-LapA; residues 1 to 378), N-terminal PA domain-truncated
LapA (ΔN-LapA; residues 89 to 378), full-length LapB (FL-LapB; residues 1 to 373), and full-length NttD
(FL-NttD; residues 1 to 373), minus N-terminal signal sequences, were amplified from 130b DNA and cloned
into N-terminal His-tagged pET-46 Ek/LIC (EMD Millipore), using primers JG1 to JG8 (Table S3). Expression of
the recombinant proteins in E. coliwas inducedwith 1mM IPTG (opyl--D-thiogalactopyranoside) at an optical
density at 600 nm (OD600) of 0.6, and cells were harvested after overnight growth at 18°C with shaking. Cells
were suspended in a mixture containing 20 mM Tris-HCl (pH 8), 200 mM NaCl, 5 mM MgCl2, 1 mg/ml DNase
I, and 5 mg/ml lysozyme and were lysed by sonication. Recombinant proteins were purified using nickel-
affinity chromatography (Qiagen) followed by gel filtration using a Superdex 75 column (GE Healthcare)
equilibrated in 20 mM Tris–HCl (pH 8)–200 mM NaCl.
Enzyme assays. Cell-free supernatants collected from late-log BYE cultures were assayed for pro-
tease, acid phosphatase, and lipase activities as previously described (50, 64). To assess secreted
aminopeptidase activity, two previously described methods were used (30). Leucine, lysine, methionine,
glycine, aspartate, isoleucine, proline, glutamate, and valine aminopeptidase activities were measured by








Resolution (Å) 99.55–1.87 (1.87–1.92)
No. of unique observations 66,414 (4,808)
Rsymb 0.063 (1.2)
I/I 12.5 (3.7)




No. of protein residues 719
No. of water molecules 313
No. of ions 4 Zn ions
RMSD stereochemistryd
Bond lengths (Å) 0.022
Bond angles (°) 2.045
Ramachandran analysise
Residues in outlier regions (%) 0.0
Residues in favored regions (%) 98.6
Residues in allowed regions (%) 100
aNumbers in parentheses refer to the outermost resolution shell.
bRsym  |I  I|/I, where I is the integrated intensity of a given reflection and I is the mean
intensity of multiple corresponding symmetry-related reflections.
cRwork  ||Fo  |Fc||/Fo, where Fo and Fc are the observed and calculated structure factors, respectively.
Rfree  Rwork values calculated using 10% random data excluded from the refinement.
dThe RMSD stereochemistry value represents the deviation from ideal values.
eRamachandran analysis was carried out using Molprobity (81).
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the release of p-nitroanilide (p-NA) from L-leucine p-NA, L-lysine p-NA, L-methionine p-NA, glycine p-NA,
L-aspartate p-NA (Chem-Impex), L-isoleucine p-NA (Chem-Impex), L-proline p-NA (MP Biomedicals),
L-glutamate p-NA (Chem-Impex), and L-valine p-NA (Chem-Impex), respectively (30). Phenylalanine,
alanine, and serine aminopeptidase activities were measured by release of -naphthylamide (-NA) from
L-phenylalanine -NA, L-alanine -NA, and L-serine -NA (Chem-Impex), respectively (30). Purified
LapA-FL and LapA-ΔN were diluted to a concentration of 500 nM in the reaction buffers and assayed as
described above. One unit of activity is equal to that which catalyzes the conversion of 1 mol
substrate/min, and molecular activity was expressed as the number of units per micromole of purified
enzyme, based on standard curves corresponding to p-NA and -NA (30, 69). Assays for -mannosidase,
-mannosidase, -galactosidase, and endo-1,4--mannanase were as previously described (70–72).
Assays for the cleavage, activation, and inhibition of aminopeptidases. To assay for the ability
of secreted proteins to cleave aminopeptidases, 10 g of purified LapB-FL or LapA-FL was incubated at
37°C for up to 2 h with 50 l of 1 or 1:10-diluted late-log-phase culture supernatants, respectively.
Samples (10 l) were collected on ice and were then subjected to SDS-PAGE. Protein was visualized with
SimplyBlue SafeStain (Thermo Scientific). Immunoblots were done as previously described (17), with
recombinant protein detected with mouse anti-His (Millipore; clone HIS.H8). For real-time monitoring of
LapA-FL cleavage and resultant activation, LapA-FL (500 nM) was added to the assay buffer containing
3 mM p-NA-based substrate and the supernatant (1:10 final concentration). Absorbance was monitored
at 405 nm. LapA inhibition assays were done using 500 nM LapA-ΔN incubated with serial dilutions of
bestatin. Residual activity following treatment was determined based on release of p-NA from L-leucine–
p-NA as described above.
Crystal structure determination. Crystallization of LapA (10 mg/ml) was done using the sitting-drop
vapor-diffusion method and growth at 293 K in 0.15 M ammonium sulfate–0.1 M 4-morpholineethane-
sulfonate (pH 5.5)–25% (wt/vol) polyethylene glycol 4000. Crystals were soaked for 30 to 60 s in
cryoprotection solution (well solution supplemented with 20% glycerol) and flash-cooled in liquid
nitrogen. Diffraction data were collected at 100 K on Beamline I03 at the Diamond Light Source (DLS),
United Kingdom. Data were processed using XDS (73) and scaled using AIMLESS (74). Initial phases were
obtained using PHASER (75) with the structure of LapB (41) as the search model. Density modification
was done with PARROT (76) followed by automated model building with ARPWARP (77). The remaining
structure was manually built within COOT (78), and refinement was carried out with refmac (79) using
noncrystallographic symmetry and translation-libration-screw groups. Ten percent of the reflections
were omitted for cross-validation. Processing and refinement statistics for the final model are given in
Table 4.
Accession number(s). Coordinates and structure factors have been deposited in the wwPDB under
PDB code 6ESL.
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